Plain-English translation of NCT07559396 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called to understand how it works in people with severe kidney disease or end-stage kidney disease. The study will measure how the medication moves through your body and whether it is safe for people with serious kidney problems. This is the first time this medication is being studied in patients with kidney disease.
When your kidneys don't work well, medications can build up in your body differently than they do in people with healthy kidneys. This study exists to make sure this medication is safe and works properly for people with severe kidney disease before it can be used more widely.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you will take the medication by mouth as directed by the research team. You will have your blood and other lab tests done to monitor your safety and how your body handles the medication. The study will involve visits to the research clinic where the doctors and nurses will check on you and ask about any side effects or health changes you experience.
AI-generated summary from trial data ยท Jul 20, 2026 ยท Not medical advice
United States